ORIC Pharmaceuticals, Inc. (ORIC) Tops Q2 EPS by 7c

August 11, 2023 5:29 AM EDT

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q2 EPS of ($0.50), $0.07 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings